Astrazeneca AZN
NYSE AZN
$186.58 -0.24 (-0.13%)
At close: Nov 6, 2026 · 4:00 PM EST

Astrazeneca (AZN) Gains from Investment Securities (2009 - 2014)

Updated

Astrazeneca (AZN) recorded Gains from Investment Securities of $776 million in FY2021.

Analysis

Astrazeneca (AZN) Gains from Investment Securities (2009 - 2014) Analysis & Trends

Starting with FY2016, Astrazeneca's Gains from Investment Securities history includes 5 years.

  • Annual Gains from Investment Securities has a five-year compound annual growth rate of 80.1% (FY2016 to FY2021).
  • The FY2021 figure is the highest annual Gains from Investment Securities in data going back to FY2016.
  • Per Business Quant data, AZN's Gains from Investment Securities was -$172 million in FY2019, $113 million in FY2018 (-45.9%) and $209 million in FY2017 (+409.8%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn
10 Vertex Pharmaceuticals 138.73 Bn 110.72 Bn 2.91 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 -7.13 Bn
Dec 31, 2013 -3.11 Bn
Dec 31, 2012 -5.61 Bn
Dec 31, 2011 577.00 Mn
Dec 31, 2010 -2.24 Bn
Dec 31, 2009 -1.18 Bn
API Access

Astrazeneca Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=AZN&period=max&api_key=YOUR_API_KEY